Rituximab and intravenous immune globulin for desensitization during renal transplantation. (Record no. 18115820)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01918 a2200541 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515130324.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMoa0707894 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Vo, Ashley A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20080722 |
245 00 - TITLE STATEMENT | |
Title | Rituximab and intravenous immune globulin for desensitization during renal transplantation. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | Jul 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 242-51 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD19 |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antigens, CD20 |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Creatinine |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Desensitization, Immunologic |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Graft Rejection |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HLA Antigens |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunoglobulins, Intravenous |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunologic Factors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunosuppression Therapy |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kidney Transplantation |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rituximab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lukovsky, Marina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Toyoda, Mieko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Jennifer |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Reinsmoen, Nancy L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lai, Chih-Hung |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peng, Alice |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Villicana, Rafael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jordan, Stanley C |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 359 |
-- | no. 3 |
-- | p. 242-51 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa0707894">https://doi.org/10.1056/NEJMoa0707894</a> |
Public note | Available from publisher's website |
No items available.